Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Martin Hentemann,Jill Wood,William Scott,Martin Michels,Ann-Marie Campbell,Ann-Marie Bullion,Bruce R. Rowley,Aniko Redman
申请号：
US15398916
公开号：
USRE046856E1
申请日:
2017.01.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyperproliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
